SOP for Incorporation of Bioactive Molecules in Nanoparticle-Based Formulations

SOP for Incorporation of Bioactive Molecules in Nanoparticle-Based Formulations

Standard Operating Procedure for Incorporation of Bioactive Molecules in Nanoparticle-Based Formulations

1) Purpose

This SOP outlines the procedure for incorporating bioactive molecules, such as proteins, peptides, or small molecules, into nanoparticle formulations for targeted drug delivery or therapeutic applications.

2) Scope

This SOP applies to personnel involved in the preparation and characterization of nanoparticles loaded with bioactive molecules for various biomedical applications.

3) Responsibilities

  • Operators: Responsible for incorporating bioactive molecules into nanoparticle formulations following this SOP.
  • QA: Ensures the nanoparticles meet specifications for bioactivity, size, and stability.
See also  SOP for Optimization of Particle Size in Nanoparticle Formulations

4) Procedure

4.1 Selection of Bioactive Molecule

4.1.1 Compatibility Check

  • 4.1.1.1 Select bioactive molecules, such as proteins or peptides, that are stable and compatible with the nanoparticle matrix (e.g., PLGA or chitosan).

4.2 Nanoparticle Preparation

4.2.1 Solvent Evaporation or Nanoprecipitation

  • 4.2.1.1 Use solvent evaporation or nanoprecipitation techniques to prepare nanoparticles, ensuring the bioactive molecule is incorporated into the formulation.

4.3 Bioactive Molecule Loading

4.3.1 Incorporation Techniques

  • 4.3.1.1 Incorporate the bioactive molecule during nanoparticle formation or post-formulation by adsorption or encapsulation techniques.

4.4 Characterization

4.4.1 Particle Size Measurement

  • 4.4.1.1 Measure the particle size using dynamic light scattering (DLS) to ensure the nanoparticles are within the desired size range (100–300 nm).
See also  Nanoparticle Formulation : SOP for Use of Surfactants in Nanoparticle Formulations

4.4.2 Bioactivity Assay

  • 4.4.2.1 Perform a bioactivity assay to confirm the activity of the bioactive molecule has been
preserved during the formulation process.

4.5 Stability Testing

4.5.1 Stability Assay

  • 4.5.1.1 Conduct stability studies to ensure the nanoparticles maintain their integrity and bioactivity during storage.

4.6 Storage

4.6.1 Storage Conditions

  • 4.6.1.1 Store the nanoparticles containing bioactive molecules in sterile containers at 4°C or room temperature, depending on the stability of the bioactive molecule.

5) Abbreviations, if any

  • DLS: Dynamic Light Scattering

6) Documents, if any

  • Bioactive Molecule Nanoparticle Formulation Logbook

7) References, if any

  • Protocols for incorporating bioactive molecules in nanoparticle formulations

8) SOP Version

Version 1.0

Annexure

Bioactive Molecule Nanoparticle Formulation Logbook Template

Date Batch Number Bioactive Molecule Particle Size Bioactivity Results Operator Initials QA Initials
DD/MM/YYYY Batch Number Molecule Name Size in nm Pass/Fail Operator Name QA Name
           
See also  Nanoparticle Formulation : SOP for Formation of Solid Lipid Nanoparticles (SLNs)

Related Posts